Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Long-Term Deferred Tax: 2022

Historic Long-Term Deferred Tax for Therapeutics (LENZ) over the last 1 years, with Dec 2022 value amounting to $39.3 million.

  • Therapeutics' Long-Term Deferred Tax was N/A to $39.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $39.3 million, marking a year-over-year change of. This contributed to the annual value of $39.3 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Therapeutics reported Long-Term Deferred Tax of $39.3 million as of FY2022.
  • Therapeutics' 5-year Long-Term Deferred Tax high stood at $39.3 million for FY2022, and its period low was $39.3 million during FY2022.
  • For the 1-year period, Therapeutics' Long-Term Deferred Tax averaged around $39.3 million, with its median value being $39.3 million (2022).